Stage III Ovarian Epithelial Cancer Completed Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01155258Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment